ABT
$116.64+2.19%Real quote · delayedMedical devices🏛️ Company factsSEC filings + FINRA official data
Annual revenue $44.3B · latest quarter up 7.8% YoY · profitable (FY net income $6.5B) · short activity above its recent average — bears adding.
FY revenue
$44.3B
2025-12
Latest Q YoY
+7.8%
Gross margin
13.8%
FY net income
$6.5B
Diluted EPS
$3.73
Short volume
58.6%
20d avg 51% · shorts building
🐋 5%+ ownership filings (last 180d)
The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.
- 2026-04-29passive (13G)VANGUARD CAPITAL MANAGEMENT LLC
- 2026-03-26passive (13G)VANGUARD GROUP INC
🎯 Market expectations
Expectation reliability High · 80/100Nasdaq analyst consensus · the pre-news baseline
- Jun 2026$1.31 vs $1.28+2.34%
- Mar 2026$1.15 vs $1.14+0.88%
- Dec 2025$1.50 vs $1.500%
- Sep 2025$1.30 vs $1.300%
It has tracked consensus closely — no systematic over- or under-shooting.
Analyst estimates, not our forecast · not investment advice
🕰️ Price × news · engine report card
Drag to pan, scroll to zoom · dot = engine's call · color = outcome, arrow = direction
📜 Call history (newest first
1 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view
Sign up · free 7-day trial →Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.
Sign up · free 7-day trial →